Skip to main content

The European Journal of Health Economics

Ausgabe 5/2023

Inhalt (12 Artikel)

Open Access Original Paper

Does diagnostic testing always decrease antibiotics prescriptions?

F. Antoñanzas, C. A. Juárez-Castelló, R. Rodríguez-Ibeas

Open Access COVID-19 Original Paper

The ‘welcomed lockdown’ hypothesis? Mental wellbeing and mobility restrictions

Joan Costa-Font, Martin Knapp, Cristina Vilaplana-Prieto

Open Access Original Paper

Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries

Hamraz Mokri, Ingelin Kvamme, Linda de Vries, Matthijs Versteegh, Pieter van Baal

Original Paper

Assessing Taiwan’s pay-for-performance program for diabetes care: a cost–benefit net value approach

Jui-fen Rachel Lu, Ying Isabel Chen, Karen Eggleston, Chih-Hung Chen, Brian Chen

Open Access COVID-19 Original Paper

Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic

Yi Wang, Nantasit Luangasanatip, Wirichada Pan–ngum, Wanrudee Isaranuwatchai, Juthamas Prawjaeng, Sompob Saralamba, Christopher Painter, Jamaica Roanne Briones, Yot Teerawattananon

Open Access COVID-19 Original Paper

Were we happy and we didn’t know it? A subjective dynamic and financial assessment pre-, during and post-COVID-19

Gabriela-Mihaela Mureșan, Viorela-Ligia Văidean, Codruța Mare, Monica Violeta Achim

Original Paper

Obesity and metabolic state are associated with increased healthcare resource and medication use and costs: a Finnish population-based study

Aino Vesikansa, Juha Mehtälä, Katja Mutanen, Annamari Lundqvist, Tiina Laatikainen, Tero Ylisaukko-oja, Tero Saukkonen, Kirsi H. Pietiläinen

Open Access Original Paper

An econometric approach to aggregating multiple cardiovascular outcomes in German hospitals

Angela Meggiolaro, Carl Rudolf Blankart, Tom Stargardt, Jonas Schreyögg

Open Access Original Paper

Dividend policy issues in the European pharmaceutical industry: new empirical evidence

Tobias Basse, Christoph Schwarzbach, J.-Matthias Graf von der Schulenburg

Open Access Original Paper

Estimating the willingness-to-pay to avoid the consequences of foodborne illnesses: a discrete choice experiment

Kathleen Manipis, Brendan Mulhern, Philip Haywood, Rosalie Viney, Stephen Goodall